Advertisement

Nutrition Care for Patients with Cystic Fibrosis: An Evidence Analysis Center Scoping Review

      Nutrition is a crucial aspect of care for patients with cystic fibrosis (CF). In order to inform nutrition care for registered dietitian nutritionists (RDNs) who serve these patients, the Evidence Analysis Library (EAL) at the Academy of Nutrition and Dietetics (Academy) set out to determine the need for a systematic review (SR) and evidence-based practice guideline (EBPG) for RDNs by conducting an evidence scoping review. In an evidence scoping review, availability of literature on a broad topic is identified and categorized to describe the nature and extent of the literature in the topic area.
      • Arskey H.
      • O'Malley L.
      Scoping studies: Towards a methodological framework..
      • Levac D.
      • Colquhoun H.
      • O'Brien K.K.
      Scoping studies: Advancing the methodology.

      Institute TJB. Joanna Briggs Institute Reviewers’ Manual. 2015 edition / Supplement 2015, Australia.

      This information may be used to define the scope of an SR, as well as inform the SR’s research questions. The end product of an evidence scoping review includes presentation and description of the literature available on a particular topic but does not include data synthesis or quality assessment of studies and typically does not include results of the primary studies.
      • Arskey H.
      • O'Malley L.
      Scoping studies: Towards a methodological framework..
      Results of an evidence scoping review can inform an SR expert workgroup about where, within a broad topic area, SRs are lacking (ie, where primary research exists, but current SRs do not exist). In addition, an evidence scoping review can identify where there is sufficient synthesized evidence and help to prevent duplication of efforts to conserve resources. Evidence scoping reviews can also inform researchers of where there are research gaps in primary literature that need to be addressed to advance, in this case, nutrition practice.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arskey H.
        • O'Malley L.
        Scoping studies: Towards a methodological framework..
        Int J Social Res Methodol. 2005; 8
        • Levac D.
        • Colquhoun H.
        • O'Brien K.K.
        Scoping studies: Advancing the methodology.
        Implement Sci. 2010; 5: 69
      1. Institute TJB. Joanna Briggs Institute Reviewers’ Manual. 2015 edition / Supplement 2015, Australia.

      2. About Cystic Fibrosis. https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/. Accessed November 7, 2017.

        • Thomson M.A.
        • Quirk P.
        • Swanson C.E.
        • et al.
        Nutritional growth retardation is associated with defective lung growth in cystic fibrosis: A preventable determinant of progressive pulmonary dysfunction.
        Nutrition. 1995; 11: 350-354
        • Corey M.
        • McLaughlin F.J.
        • Williams M.
        • Levison H.
        A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.
        J Clin Epidemiol. 1988; 41: 583-591
        • Sharma R.
        • Florea V.G.
        • Bolger A.P.
        • et al.
        Wasting as an independent predictor of mortality in patients with cystic fibrosis.
        Thorax. 2001; 56: 746-750
        • Vieni G.
        • Faraci S.
        • Collura M.
        • et al.
        Stunting is an independent predictor of mortality in patients with cystic fibrosis.
        Clin Nutr. 2013; 32: 382-385
        • Matel J.L.
        • Milla C.E.
        Nutrition in cystic fibrosis.
        Semin Respir Crit Care Med. 2009; 30: 579-586
        • Borowitz D.
        The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis.
        Curr Opin Pulm Med. 1996; 2: 457-461
        • Turck D.
        • Braegger C.P.
        • Colombo C.
        • et al.
        ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis.
        Clin Nutr. 2016; 35: 557-577
      3. Saxby N, Painter C, Kench A, King S, Crowder T, van der Haak N, and the Australian and New Zealand Cystic Fibrosis Nutrition Guideline Authorship Group (2017). Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand, ed. Scott C. Bell, Thoracic Society of Australia and New Zealand, Sydney.

      4. Carrier Testing for Cystic Fibrosis. What is CF? https://www.cff.org/What-is-CF/Testing/Carrier-Testing-for-Cystic-Fibrosis/. Accessed January 9, 2018.

      5. Dietetics AoNa. Nutrition Care Process. 2017. http://www.eatrightpro.org/resources/practice/practice-resources/nutrition-care-process. Accessed November 8, 2017.

        • Sermet-Gaudelus I.
        • Mayell S.J.
        • Southern K.W.
        Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening.
        J Cyst Fibros. 2010; 9: 323-329
        • Borowitz D.
        • Robinson K.A.
        • Rosenfeld M.
        • et al.
        Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.
        J Pediatr. 2009; 155: S73-S93
        • Lahiri T.
        • Hempstead S.E.
        • Brady C.
        • et al.
        Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis.
        Pediatrics. 2016; 137
        • Edenborough F.P.
        • Borgo G.
        • Knoop C.
        • et al.
        Guidelines for the management of pregnancy in women with cystic fibrosis.
        J Cyst Fibros. 2008; 7: S2-S32
        • Moran A.
        • Pillay K.
        • Becker D.J.
        • Acerini C.L.
        • International Society for Pediatric and Adolescent Diabetes
        ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents.
        Pediatr Diabetes. 2014; 15: 65-76
        • Holick M.F.
        • Binkley N.C.
        • Bischoff-Ferrari H.A.
        • et al.
        Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline.
        J Clin Endocrinol Metab. 2011; 96: 1911-1930
        • Tangpricha V.
        • Kelly A.
        • Stephenson A.
        • et al.
        An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: Evidence-based recommendations from the Cystic Fibrosis Foundation.
        J Clin Endocrinol Metab. 2012; 97: 1082-1093
        • Schwarzenberg S.J.
        • Hempstead S.E.
        • McDonald C.M.
        • et al.
        Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines.
        J Cyst Fibros. 2016; 15: 724-735
        • Zhang Z.
        • Shoff S.M.
        • Lai H.J.
        Incorporating genetic potential when evaluating stature in children with cystic fibrosis.
        J Cyst Fibros. 2010; 9: 135-142
        • Zhang Z.
        • Shoff S.M.
        • Lai H.J.
        Comparing the use of Centers for Disease Control and Prevention and World Health Organization growth charts in children with cystic fibrosis through 2 years of age.
        J Pediatr. 2015; 167: 1089-1095
        • Machogu E.
        • Cao Y.
        • Miller T.
        • et al.
        Comparison of WHO and CDC growth charts in predicting pulmonary outcomes in cystic fibrosis.
        J Pediatr Gastroenterol Nutr. 2015; 60: 378-383
        • Randlesome K.
        • Bryon M.
        • Evangeli M.
        Developing a measure of eating attitudes and behaviours in cystic fibrosis.
        J Cyst Fibros. 2013; 12: 15-21
        • King S.
        • Wilson J.
        • Kotsimbos T.
        • Bailey M.
        • Nyulasi I.
        Body composition assessment in adults with cystic fibrosis: Comparison of dual-energy x-ray absorptiometry with skinfolds and bioelectrical impedance analysis.
        Nutrition. 2005; 21: 1087-1094
        • King S.J.
        • Nyulasi I.B.
        • Strauss B.J.G.
        • Kotsimbos T.
        • Bailey M.
        • Wilson J.W.
        Fat-free mass depletion in cystic fibrosis: Associated with lung disease severity but poorly detected by body mass index.
        Nutrition. 2010; 26: 753-759
        • Flohr F.
        • Lutz A.
        • App E.M.
        • Matthys H.
        • Reincke M.
        Bone mineral density and quantitative ultrasound in adults with cystic fibrosis.
        Eur J Endocrinol. 2002; 146: 531-536
        • Olveira G.
        • Olveira C.
        • Casado-Miranda E.
        • et al.
        Markers for the validation of reported dietary intake in adults with cystic fibrosis.
        J Am Diet Assoc. 2009; 109: 1704-1711
        • Hollander F.M.
        • de Roos N.M.
        • de Vries J.H.M.
        • van Berkhout F.T.
        Assessment of nutritional status in adult patients with cystic fibrosis: Whole-body bioimpedance vs body mass index, skinfolds, and leg-to-leg bioimpedance.
        J Am Diet Assoc. 2005; 105: 549-555
        • Speeckaert M.M.
        • Wehlou C.
        • Vandewalle S.
        • Taes Y.E.
        • Robberecht E.
        • Delanghe J.R.
        Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients.
        Clin Chem Lab Med. 2008; 46: 365-370
        • Mueller-Brandes C.
        • Holl R.W.
        • Nastoll M.
        • Ballmann M.
        New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.
        Eur Respir J. 2005; 25: 715-717
        • Alicandro G.
        • Battezzati A.
        • Bianchi M.L.
        • et al.
        Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients.
        J Cyst Fibros. 2015; 14: 784-791
        • Piazza-Waggoner C.
        • Driscoll K.A.
        • Gilman D.K.
        • Powers S.W.
        A comparison using parent report and direct observation of mealtime behaviors in young children with cystic fibrosis: Implications for practical and empirically based behavioral assessment in routine clinical care.
        Child Health Care. 2008; 37: 38-48
        • Scheuing N.
        • Holl R.W.
        • Dockter G.
        • et al.
        High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: A multicenter screening study.
        PloS One. 2014; 9: e112578
        • Engelen M.P.
        • Com G.
        • Deutz N.E.
        Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis.
        Clin Nutr. 2014; 33: 1117-1121
        • Quirk P.C.
        • Ward L.C.
        • Thomas B.J.
        • Holt T.L.
        • Shepherd R.W.
        • Cornish B.H.
        Evaluation of bioelectrical impedance for prospective nutritional assessment in cystic fibrosis.
        Nutrition. 1997; 13: 412-416
        • Williams J.E.
        • Wells J.C.
        • Wilson C.M.
        • Haroun D.
        • Lucas A.
        • Fewtrell M.S.
        Evaluation of Lunar Prodigy dual-energy x-ray absorptiometry for assessing body composition in healthy persons and patients by comparison with the criterion 4-component model.
        Am J Clin Nutr. 2006; 83: 1047-1054
        • Wells G.D.
        • Heale L.
        • Schneiderman J.E.
        • et al.
        Assessment of body composition in pediatric patients with cystic fibrosis.
        Pediatr Pulmonol. 2008; 43: 1025-1032
        • Reilly J.J.
        • Evans T.J.
        • Wilkinson J.
        • Paton J.Y.
        Adequacy of clinical formulae for estimation of energy requirements in children with cystic fibrosis.
        Arch Dis Child. 1999; 81: 120-124
        • Trabulsi J.
        • Ittenbach R.F.
        • Schall J.I.
        • et al.
        Evaluation of formulas for calculating total energy requirements of preadolescent children with cystic fibrosis.
        Am J Clin Nutr. 2007; 85: 144-151
        • Wiedemann B.
        • Paul K.D.
        • Stern M.
        • Wagner T.O.
        • Hirche T.O.
        Evaluation of body mass index percentiles for assessment of malnutrition in children with cystic fibrosis.
        Eur J Clin Nutr. 2007; 61: 759-768
        • McNaughton S.A.
        • Shepherd R.W.
        • Greer R.G.
        • Cleghorn G.J.
        • Thomas B.J.
        Nutritional status of children with cystic fibrosis measured by total body potassium as a marker of body cell mass: Lack of sensitivity of anthropometric measures.
        J Pediatr. 2000; 136: 188-194
        • Groeneweg M.
        • Tan S.
        • Boot A.M.
        • de Jongste J.C.
        • Bouquet J.
        • Sinaasappel M.
        Assessment of nutritional status in children with cystic fibrosis: Conventional anthropometry and bioelectrical impedance analysis. A cross-sectional study in Dutch patients.
        J Cyst Fibros. 2002; 1: 276-280
        • McDonald C.M.
        Validation of a nutrition risk screening tool for children and adolescents with cystic fibrosis ages 2-20 years.
        J Pediatr Gastroenterol Nutr. 2008; 46: 438-446
        • Lai H.J.
        • Shoff S.M.
        Classification of malnutrition in cystic fibrosis: Implications for evaluating and benchmarking clinical practice performance.
        Am J Clin Nutr. 2008; 88: 161-166
        • Engelen M.P.K.J.
        • Schroder R.
        • Van der Hoorn K.
        • Deutz N.E.P.
        • Com G.
        Use of body mass index percentile to identify fat-free mass depletion in children with cystic fibrosis.
        Clin Nutr. 2012; 31: 927-933
        • Badcock N.R.
        • Parsons D.
        • Staugas R.E.
        • Aldis J.J.E.
        • Couper R.T.L.
        Vitamin E, peroxidative and non-peroxidative free radical damage markers, and sample collection timing in children and adolescents with cystic fibrosis.
        Aust J Nutr Diet. 2000; 57: 79-83
        • Trabulsi J.
        • Schall J.I.
        • Ittenbach R.F.
        • et al.
        Energy balance and the accuracy of reported energy intake in preadolescent children with cystic fibrosis.
        Am J Clin Nutr. 2006; 84: 523-530
        • Souza Dos Santos Simon M.I.
        • Forte G.C.
        • da Silva Pereira J.
        • da Fonseca Andrade Procianoy E.
        • Drehmer M.
        Validation of a nutrition screening tool for pediatric patients with cystic fibrosis.
        J Acad Nutr Diet. 2016; 116: 813-818
        • Souza dos Santos Simon M.I.
        • Drehmer M.
        • de Abreu E.S.F.A.
        • et al.
        Association of nutritional status, plasma, albumin levels and pulmonary function in cystic fibrosis.
        Nutr Hosp. 2011; 26: 1322-1327
        • de Meer K.
        • Gulmans V.A.
        • Westerterp K.R.
        • Houwen R.H.
        • Berger R.
        Skinfold measurements in children with cystic fibrosis: Monitoring fat-free mass and exercise effects.
        Eur J Pediatr. 1999; 158: 800-806
        • Murphy A.J.
        • Buntain H.M.
        • Wong J.C.
        • Greer R.M.
        • Wainwright C.E.
        • Davies P.S.
        The use of air displacement plethysmography in children and adolescents with cystic fibrosis.
        Eur J Clin Nutr. 2004; 58: 985-989
        • Hollander F.M.
        • Kok A.
        • de Roos N.M.
        • Belle-van Meerkerk G.
        • van de Graaf E.A.
        Prediction equations underestimate resting energy expenditure in patients with end-stage cystic fibrosis.
        Nutr Clin Pract. 2017; 32: 116-121
        • Stallings V.A.
        • Stark L.J.
        • Robinson K.A.
        • Feranchak A.P.
        • Quinton H.
        Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: Results of a systematic review.
        J Am Diet Assoc. 2008; 108: 832-839
        • Calella P.
        • Valerio G.
        • Brodlie M.
        • McCabe H.
        • Siervo M.
        Cystic fibrosis and body composition in children and adults: A systematic review.
        PROSPERO. 2017; (CRD42017062559)
        • Quintano J.
        Systematic review: Dietary intake in children with cystic fibrosis-assessment of energy and fat intake, and the impact on markers of nutritional status (growth, serum lipids and fat soluble vitamins).
        PROSPERO. 2015; (CRD42015019904)
        • Durieu I.
        • Vericel E.
        • Guichardant D.
        • et al.
        Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study.
        J Cyst Fibros. 2007; 6: 320-326
        • Turowski J.B.
        • Pietrofesa R.A.
        • Lawson J.A.
        • Christofidou-Solomidou M.
        • Hadjiliadis D.
        Flaxseed modulates inflammatory and oxidative stress biomarkers in cystic fibrosis: A pilot study.
        BMC Complement Altern Med. 2015; 15: 148
        • Keen C.
        • Olin A.C.
        • Eriksson S.
        • et al.
        Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis.
        J Pediatr Gastroenterol Nutr. 2010; 50: 537-544
        • Panchaud A.
        • Sauty A.
        • Kernen Y.
        • et al.
        Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: A randomized, crossover placebo-controlled trial.
        Clin Nutr. 2006; 25: 418-427
        • Brown S.A.
        • Ontjes D.A.
        • Lester G.E.
        • et al.
        Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.
        Osteoporos Int. 2003; 14: 442-449
        • Sommerburg O.
        • De Spirt S.
        • Mattern A.
        • et al.
        Supplementation with red palm oil increases beta-carotene and vitamin A blood levels in patients with cystic fibrosis.
        Mediators Inflamm. 2015; 2015: 817127
        • Bruzzese E.
        • Raia V.
        • Gaudiello G.
        • et al.
        Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
        Aliment Pharmacol Ther. 2004; 20: 813-819
        • Jacquemin E.
        • Hermeziu B.
        • Kibleur Y.
        • et al.
        Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis.
        J Clin Pharm Ther. 2009; 34: 515-522
        • Shepherd D.
        • Belessis Y.
        • Katz T.
        • Morton J.
        • Field P.
        • Jaffe A.
        Single high-dose oral vitamin D3 (stoss) therapy–a solution to vitamin D deficiency in children with cystic fibrosis?.
        J Cyst Fibros. 2013; 12: 177-182
        • Boas S.R.
        • Hageman J.R.
        • Ho L.T.
        • Liveris M.
        Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.
        J Cyst Fibros. 2009; 8: 270-272
        • Boyle M.P.
        • Noschese M.L.
        • Watts S.L.
        • et al.
        Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.
        Am J Respir Crit Care Med. 2005; 172: 212-217
        • Wilson D.C.
        • Rashid M.
        • Durie P.R.
        • et al.
        Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination.
        J Pediatr. 2001; 138: 851-855
        • Scambi C.
        • De Franceschi L.
        • Guarini P.
        • et al.
        Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: A single arm trial.
        PloS One. 2009; 4: e4782
        • Beker L.T.
        • Ahrens R.A.
        • Fink R.J.
        • et al.
        Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients.
        J Pediatr Gastroenterol Nutr. 1997; 24: 512-517
        • Sadowska-Woda I.
        • Rachel M.
        • Pazdan J.
        • Bieszczad-Bedrejczuk E.
        • Pawliszak K.
        Nutritional supplement attenuates selected oxidative stress markers in pediatric patients with cystic fibrosis.
        Nutr Res. 2011; 31: 509-518
        • Caramia G.
        • Cocchi M.
        • Gagliardini R.
        • Malavolta M.
        • Mozzon M.
        • Frega N.G.
        Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
        La Pediatr Med Chir. 2003; 25: 42-49
        • Stapleton D.R.
        • Gurrin L.C.
        • Zubrick S.R.
        • Silburn S.R.
        • Sherriff J.L.
        • Sly P.D.
        The effect of ‘Go and Grow with CF’ on nutrition and pancreatic enzyme knowledge of children with cystic fibrosis.
        Aust J Nutr Diet. 2001; 58: 164-168
        • Stark E.A.
        Contribution of behavior therapy to dietary treatment in cystic fibrosis: A randomized controlled study with 2-year follow-up.
        Behav Ther. 2003; 34: 237-258
        • Rust P.
        • Eichler I.
        • Renner S.
        • Elmadfa I.
        Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
        Int J Vitam Nutr Res. 1998; 68: 83-87
        • Haworth C.S.
        • Jones A.M.
        • Adams J.E.
        • Selby P.L.
        • Webb A.K.
        Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis.
        J Cyst Fibros. 2004; 3: 233-236
        • Best K.
        • McCoy K.
        • Gemma S.
        • Disilvestro R.A.
        Copper enzyme activities in cystic fibrosis before and after copper supplementation plus or minus zinc.
        Metab Clin Exp. 2004; 53: 37-41
        • Bruzzese E.
        • Callegari M.L.
        • Raia V.
        • et al.
        Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: A randomised clinical trial.
        PloS One. 2014; 9: e87796
        • Fallahi G.
        • Motamed F.
        • Yousefi A.
        • et al.
        The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
        Turk J Pediatr. 2013; 55: 475-478
        • del Campo R.
        • Garriga M.
        • Perez-Aragon A.
        • et al.
        Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study.
        J Cyst Fibros. 2014; 13: 716-722
        • Drury D.
        • Grey V.L.
        • Ferland G.
        • Gundberg C.
        • Lands L.C.
        Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis.
        J Cyst Fibros. 2008; 7: 457-459
        • Papas K.
        • Kalbfleisch J.
        • Mohon R.
        Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients.
        Dig Dis Sci. 2007; 52: 347-352
        • Khazai N.B.
        • Judd S.E.
        • Jeng L.
        • et al.
        Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: Comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
        J Clin Endocrinol Metab. 2009; 94: 2037-2043
        • Grossmann R.E.
        • Zughaier S.M.
        • Liu S.
        • et al.
        Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation.
        Eur J Clin Nutr. 2012; 66: 1072-1074
        • Hillman L.S.
        • Cassidy J.T.
        • Popescu M.F.
        • Hewett J.E.
        • Kyger J.
        • Robertson J.D.
        Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: Effect of supplementation with vitamin D and calcium.
        Pediatr Pulmonol. 2008; 43: 772-780
        • Alvarez J.A.
        • Chong E.Y.
        • Walker D.I.
        • et al.
        Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration.
        Metab Clin Exp. 2017; 70: 31-41
        • Simoneau T.
        • Sawicki G.S.
        • Milliren C.E.
        • Feldman H.A.
        • Gordon C.M.
        A randomized controlled trial of vitamin D replacement strategies in pediatric patients with CF.
        J Cyst Fibros. 2016; 15: 234-241
        • Innis S.M.
        • Davidson A.G.
        • Melynk S.
        • James S.J.
        Choline-related supplements improve abnormal plasma methionine-homocysteine metabolites and glutathione status in children with cystic fibrosis.
        Am J Clin Nutr. 2007; 85: 702-708
        • Engelen M.P.
        • Com G.
        • Wolfe R.R.
        • Deutz N.E.
        Dietary essential amino acids are highly anabolic in pediatric patients with cystic fibrosis.
        J Cyst Fibros. 2013; 12: 445-453
        • Grey V.
        • Mohammed S.R.
        • Smountas A.A.
        • Bahlool R.
        • Lands L.C.
        Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein.
        J Cyst Fibros. 2003; 2: 195-198
        • Grasemann H.
        • Grasemann C.
        • Kurtz F.
        • Tietze-Schillings G.
        • Vester U.
        • Ratjen F.
        Oral L-arginine supplementation in cystic fibrosis patients: A placebo-controlled study.
        Eur Respir J. 2005; 25: 62-68
        • Forrester D.L.
        • Knox A.J.
        • Smyth A.R.
        • et al.
        Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial.
        Pediatr Pulmonol. 2016; 51: 253-257
        • Gottrand F.
        • Hankard R.
        • Michaud L.
        • et al.
        Effect of glucose to fat ratio on energy substrate disposal in children with cystic fibrosis fed enterally.
        Clin Nutr. 1999; 18: 297-300
        • Geukers V.G.M.
        • Oudshoorn J.H.
        • Taminiau J.A.J.
        • et al.
        Short-term protein intake and stimulation of protein synthesis in stunted children with cystic fibrosis.
        Am J Clin Nutr. 2005; 81: 605-610
        • Legris G.J.
        • Dearborn D.
        • Stern R.C.
        • et al.
        Sodium space and intravascular volume: Dietary sodium effects in cystic fibrosis and healthy adolescent subjects.
        Pediatrics. 1998; 101: 48-56
        • Savant A.P.
        • Britton L.J.
        • Petren K.
        • McColley S.A.
        • Gutierrez H.H.
        Sustained improvement in nutritional outcomes at two paediatric cystic fibrosis centres after quality improvement collaboratives.
        BMJ Qual Saf. 2014; 23: i81-i89
        • Ramirez I.
        • Filbrun A.
        • Hasan A.
        • Kidwell K.M.
        • Nasr S.Z.
        Improving nutritional status in a pediatric cystic fibrosis center.
        Pediatr Pulmonol. 2015; 50: 544-551
        • Thies N.H.
        The effect of 12 months' treatment with eicosapentaenoic acid in five children with cystic fibrosis.
        J Paediatr Child Health. 1997; 33: 349-351
        • Lloyd-Still J.D.
        • Powers C.A.
        • Hoffman D.R.
        • et al.
        Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: A randomized, controlled study.
        Nutrition. 2006; 22: 36-46
        • Adde F.V.
        • Rodrigues J.C.
        • Cardoso A.L.
        Nutritional follow-up of cystic fibrosis patients: The role of nutrition education.
        J Pediatr (Rio J). 2004; 80: 475-482
        • Stark L.J.
        • Opipari-Arrigan L.
        • Quittner A.L.
        • Bean J.
        • Powers S.W.
        The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF.
        Pediatr Pulmonol. 2011; 46: 31-35
        • Abdulhamid I.
        • Beck F.W.
        • Millard S.
        • Chen X.
        • Prasad A.
        Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis.
        Pediatr Pulmonol. 2008; 43: 281-287
        • Sharma G.
        • Lodha R.
        • Shastri S.
        • et al.
        Zinc supplementation for one year among children with cystic fibrosis does not decrease pulmonary infection.
        Respir Care. 2016; 61: 78-84
        • Gontijo-Amaral C.
        • Guimarães E.V.
        • Camargos P.
        Oral magnesium supplementation in children with cystic fibrosis improves clinical and functional variables: A double-blind, randomized, placebo-controlled crossover trial.
        Am J Clin Nutr. 2012; 96: 50-56
        • Jafari S.-A.
        • Mehdizadeh-Hakkak A.
        • Kianifar H.-R.
        • Hebrani P.
        • Ahanchian H.
        • Abbasnejad E.
        Effects of probiotics on quality of life in children with cystic fibrosis: A randomized controlled trial.
        Iran J Pediatr. 2013; 23: 669-674
        • Bruzzese E.
        • Raia V.
        • Spagnuolo M.I.
        • et al.
        Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: A pilot study.
        Clin Nutr. 2007; 26: 322-328
        • Poustie V.J.
        • Russell J.E.
        • Watling R.M.
        • Ashby D.
        • Smyth R.L.
        Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial.
        BMJ. 2006; 332: 632-636
        • Olveira G.
        • Olveira C.
        • Acosta E.
        • et al.
        Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
        Arch Bronconeumol. 2010; 46: 70-77
        • Leggieri E.
        • De Biase R.V.
        • Savi D.
        • Zullo S.
        • Halili I.
        • Quattrucci S.
        Clinical effects of diet supplementation with DHA in pediatric patients suffering from cystic fibrosis.
        Minerva Pediatr. 2013; 65: 389-398
        • Jumpsen J.A.
        • Brown N.E.
        • Thomson A.B.
        • et al.
        Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
        J Cyst Fibros. 2006; 5: 77-84
        • De Vizia B.
        • Raia V.
        • Spano C.
        • et al.
        Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
        JPEN J Parenter Enteral Nutr. 2003; 27: 52-57
        • Hanssens L.
        • Thiebaut I.
        • Lefevre N.
        • et al.
        The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study.
        Prostaglandins Leukot Essent Fatty Acids. 2016; 108: 45-50
        • Van Biervliet S.
        • Devos M.
        • Delhaye T.
        • Van Biervliet J.P.
        • Robberecht E.
        • Christophe A.
        Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
        Prostaglandins Leukot Essent Fatty Acids. 2008; 78: 109-115
        • Alicandro G.
        • Faelli N.
        • Gagliardini R.
        • et al.
        A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis.
        Prostaglandins Leukot Essent Fatty Acids. 2013; 88: 163-169
        • Ataee P.
        • Najafi M.
        • Gharagozlou M.
        • et al.
        Effect of supplementary zinc on body mass index, pulmonary function and hospitalization in children with cystic fibrosis.
        Turk J Pediatr. 2014; 56: 127-132
        • Weiss B.
        • Bujanover Y.
        • Yahav Y.
        • Vilozni D.
        • Fireman E.
        • Efrati O.
        Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: A pilot study.
        Pediatr Pulmonol. 2010; 45: 536-540
        • Papas K.A.
        • Sontag M.K.
        • Pardee C.
        • et al.
        A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis.
        J Cyst Fibros. 2008; 7: 60-67
        • Nicolaidou P.
        • Stavrinadis I.
        • Loukou I.
        • et al.
        The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis.
        Eur J Pediatr. 2006; 165: 540-545
        • Sagel S.D.
        • Sontag M.K.
        • Anthony M.M.
        • Emmett P.
        • Papas K.A.
        Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis.
        J Cyst Fibros. 2011; 10: 31-36
        • Lands L.C.
        • Iskandar M.
        • Beaudoin N.
        • Meehan B.
        • Dauletbaev N.
        • Berthiuame Y.
        Dietary supplementation with pressurized whey in patients with cystic fibrosis.
        J Med Food. 2010; 13: 77-82
        • Everard M.L.
        • Donnelly D.
        A pilot study of oral L-arginine in cystic fibrosis.
        J Cyst Fibros. 2005; 4: 67-69
        • Skypala I.J.
        • Ashworth F.A.
        • Hodson M.E.
        • et al.
        Oral nutritional supplements promote significant weight gain in cystic fibrosis patients.
        J Hum Nutr Diet. 1998; 11: 95-104
        • Kalnins D.
        • Corey M.
        • Ellis L.
        • Pencharz P.B.
        • Tullis E.
        • Durie P.R.
        Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis.
        J Pediatr. 2005; 147: 399-401
        • Steinkamp G.
        • Demmelmair H.
        • Ruhl-Bagheri I.
        • von der Hardt H.
        • Koletzko B.
        Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients.
        J Pediatr Gastroenterol Nutr. 2000; 31: 418-423
        • Powers S.W.
        • Byars K.C.
        • Mitchell M.J.
        • Patton S.R.
        • Schindler T.
        • Zeller M.H.
        A randomized pilot study of behavioral treatment to increase calorie intake in toddlers with cystic fibrosis.
        Child Health Care. 2003; 32: 297-311
        • Janicke D.M.
        • Mitchell M.J.
        • Quittner A.L.
        • Piazza-Waggoner C.
        • Stark L.J.
        The impact of behavioral intervention on family interactions at mealtime in pediatric cystic fibrosis.
        Child Health Care. 2008; 37: 49-66
        • Powers S.W.
        • Jones J.S.
        • Ferguson K.S.
        • Piazza-Waggoner C.
        • Daines C.
        • Acton J.D.
        Randomized clinical trial of behavioral and nutrition treatment to improve energy intake and growth in toddlers and preschoolers with cystic fibrosis.
        Pediatrics. 2005; 116: 1442-1450
        • Watson H.
        • Bilton D.
        • Truby H.
        A randomized controlled trial of a new behavioral home-based nutrition education program, “Eat Well with CF,” in adults with cystic fibrosis.
        J Am Diet Assoc. 2008; 108: 847-852
        • Powers S.W.
        • Stark L.J.
        • Chamberlin L.A.
        • et al.
        Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: A randomized clinical trial.
        JAMA Pediatr. 2015; 169: e150636
        • Opipari-Arrigan L.
        • Powers S.W.
        • Quittner A.L.
        • Stark L.J.
        Mealtime problems predict outcome in clinical trial to improve nutrition in children with CF.
        Pediatr Pulmonol. 2010; 45: 78-82
        • Stark L.J.
        • Quittner A.L.
        • Powers S.W.
        • et al.
        Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis.
        Arch Pediatr Adolesc Med. 2009; 163: 915-921
        • Rust P.
        • Eichler I.
        • Renner S.
        • Elmadfa I.
        Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function.
        Ann Nutr Metab. 2000; 44: 30-37
        • Renner S.
        • Rath R.
        • Rust P.
        • et al.
        Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis.
        Thorax. 2001; 56: 48-52
        • Oudshoorn J.H.
        • Klijn P.H.
        • Hofman Z.
        • et al.
        Dietary supplementation with multiple micronutrients: No beneficial effects in pediatric cystic fibrosis patients.
        J Cyst Fibros. 2007; 6: 35-40
        • Di Nardo G.
        • Oliva S.
        • Menichella A.
        • et al.
        Lactobacillus reuteri ATCC55730 in cystic fibrosis.
        J Pediatr Gastroenterol Nutr. 2014; 58: 81-86
        • Visca A.
        • Bishop C.T.
        • Hilton S.
        • Hudson V.M.
        Oral reduced L-glutathione improves growth in pediatric cystic fibrosis patients.
        J Pediatr Gastroenterol Nutr. 2015; 60: 802-810
        • Wood L.G.
        • Fitzgerald D.A.
        • Lee A.K.
        • Garg M.L.
        Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.
        Am J Clin Nutr. 2003; 77: 150-159
        • Ellis L.
        • Kalnins D.
        • Corey M.
        • Brennan J.
        • Pencharz P.
        • Durie P.
        Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study.
        J Pediatr. 1998; 132: 270-276
        • Erskine J.M.
        • Lingard C.D.
        • Sontag M.K.
        • Accurso F.J.
        Enteral nutrition for patients with cystic fibrosis: Comparison of a semi-elemental and nonelemental formula.
        J Pediatr. 1998; 132: 265-269
        • Grossmann R.E.
        • Zughaier S.M.
        • Kumari M.
        • et al.
        Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial.
        Dermatoendocrinol. 2012; 4: 191-197
        • Bonifant C.M.
        • Shevill E.
        • Chang A.B.
        Vitamin A supplementation for cystic fibrosis.
        Cochrane Database Syst Rev. 2014; : CD006751
        • Oliver C.
        • Watson H.
        Omega-3 fatty acids for cystic fibrosis.
        Cochrane Database Syst Rev. 2016; : CD002201
        • Anderson J.L.
        • Miles C.
        • Tierney A.C.
        Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review.
        J Cyst Fibros. 2017; 16: 186-197
        • Ferguson J.H.
        • Chang A.B.
        Vitamin D supplementation for cystic fibrosis.
        Cochrane Database Syst Rev. 2014; : Cd007298
        • Smyth R.L.
        Oral calorie supplements for cystic fibrosis.
        Cochrane Database Syst Rev. 2017;
        • Okebukola P.O.
        Vitamin E supplementation in people with cystic fibrosis.
        Cochrane Database Syst Rev. 2017;
        • Robinson K.A.
        • Saldanha I.J.
        • McKoy N.A.
        Management of infants with cystic fibrosis: A summary of the evidence for the Cystic Fibrosis Foundation Working Group on Care of Infants with Cystic Fibrosis.
        J Pediatr. 2009; 155: S94-S105
        • Morton A.
        • Wolfe S.
        Enteral tube feeding for cystic fibrosis.
        Cochrane Database Syst Rev. 2015; : CD001198
        • Woestenenk J.W.
        • Castelijns S.J.
        • van der Ent C.K.
        • Houwen R.H.
        Nutritional intervention in patients with cystic fibrosis: A systematic review.
        J Cyst Fibros. 2013; 12: 102-115
        • Savage E.
        • Beirne P.V.
        • Ni Chroinin M.
        • Duff A.
        • Fitzgerald T.
        • Farrell D.
        Self-management education for cystic fibrosis.
        Cochrane Database Syst Rev. 2014; : CD007641
        • Ciofu O.
        • Lykkesfeldt J.
        Antioxidant supplementation for lung disease in cystic fibrosis.
        Cochrane Database Syst Rev. 2014; : CD007020
        • Jelalian E.
        • Stark L.J.
        • Reynolds L.
        • Seifer R.
        Nutrition intervention for weight gain in cystic fibrosis: A meta analysis.
        J Pediatr. 1998; 132: 486-492
        • Santi M.
        • Milani G.P.
        • Simonetti G.D.
        • Fossali E.F.
        • Bianchetti M.G.
        • Lava S.A.
        Magnesium in cystic fibrosis–Systematic review of the literature.
        Pediatr Pulmonol. 2016; 51: 196-202
        • Poustie V.J.
        • Watling R.M.
        • Smyth R.L.
        Oral protein-energy supplements for children with chronic disease: Systematic review.
        Proc Nutr Soc. 2003; 62: 801-806
        • Jagannath V.A.
        • Fedorowicz Z.
        • Thaker V.
        • Chang A.B.
        Vitamin K supplementation for cystic fibrosis.
        Cochrane Database Syst Rev. 2015; 1: CD008482
        • Smyth R.
        • Walters S.
        Oral calorie supplements for cystic fibrosis.
        Cochrane Database Syst Rev. 2007; : CD000406
        • Sands D.
        • Mielus M.
        • Umlawska W.
        • Lipowicz A.
        • Oralewska B.
        • Walkowiak J.
        Dietary pattern and its relationship between bone mineral density in girls and boys with cystic fibrosis - preliminary report.
        Dev Period Med. 2015; 19: 105-113
        • Gavin J.
        • Ellis J.
        • Dewar A.L.
        • Rolles C.J.
        • Connett G.J.
        Dietary fibre and the occurrence of gut symptoms in cystic fibrosis.
        Arch Dis Child. 1997; 76: 35-37
        • Ziai S.
        • Coriati A.
        • St-Pierre D.
        • et al.
        Glucose fluctuations are not modulated by the proportion of calories from macronutrients or spontaneous total energy expenditure in adults with cystic fibrosis.
        Can J Diabetes. 2016; 40: 389-392
        • Walkowiak J.
        • Przyslawski J.
        Five-year prospective analysis of dietary intake and clinical status in malnourished cystic fibrosis patients.
        J Hum Nutr Diet. 2003; 16: 225-231
        • Anthony H.
        • Bines J.
        • Phelan P.
        • Paxton S.
        Relation between dietary intake and nutritional status in cystic fibrosis.
        Arch Dis Child. 1998; 78: 443-447
        • Proesmans M.
        • De Boeck K.
        Evaluation of dietary fiber intake in Belgian children with cystic fibrosis: Is there a link with gastrointestinal complaints?.
        J Pediatr Gastroenterol Nutr. 2002; 35: 610-614
        • Jadin S.A.
        • Wu G.S.
        • Zhang Z.
        • et al.
        Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.
        Am J Clin Nutr. 2011; 93: 1038-1047
        • Colombo C.
        • Costantini D.
        • Zazzeron L.
        • et al.
        Benefits of breastfeeding in cystic fibrosis: A single-centre follow-up survey.
        Acta Paediatr. 2007; 96: 1228-1232
        • Somaraju U.R.
        • Solis-Moya A.
        Pancreatic enzyme replacement therapy for people with cystic fibrosis.
        Cochrane Database Syst Rev. 2016; 11: CD008227

      Biography

      M. Rozga is a nutrition researcher, Evidence Analysis Library, Academy of Nutrition and Dietetics, Chicago, IL.

      Biography

      D. Handu is senior scientific director, Evidence Analysis Library, Academy of Nutrition and Dietetics, Chicago, IL.